Showing results (671-680 of 798) with videos related to
Sort By:
Pageof 80
Cancer|June 25, 2025
Consensus guideline for the management of colorectal cancer with peritoneal metastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal MetastasesKurt S Schultz, Varun V Bansal, Michael M Wach, et al.The European Respiratory Journal|June 6, 2020
Complications following symptom-limited thoracentesis using suctionAla Eddin S Sagar, Maria F Landaeta, Andres M Adrianza, et al.The New England Journal of Medicine|February 10, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard A Furie, Brad H Rovin, Jay P Garg, et al.The New England Journal of Medicine|March 6, 2026
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus ErythematosusRichard A Furie, Maria Dall'Era, Edward M Vital, et al.The New England Journal of Medicine|March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.The New England Journal of Medicine|July 5, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, et al.The New England Journal of Medicine|October 27, 2023
Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisMathew S Maurer, Parag Kale, Marianna Fontana, et al.Hypertension (Dallas, Tex. : 1979)|August 28, 2025
Overcoming Barriers to Developing and Implementing Novel Therapies for HypertensionKonstantin A Krychtiuk, Renato D Lopes, Victoria A Cargill, et al.The New England Journal of Medicine|August 30, 2024
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, John L Berk, Julian D Gillmore, et al.Pageof 80